During the past decade, Medical Associates Research Group conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 37 clinical trials were completed, i.e. on average, 78.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 24 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical Associates Research Group" #1 sponsor was "Gilead Sciences" with 22 trials, followed by "Bristol-Myers Squibb" with 10 trials sponsored, "Celgene" with 9 trials sponsored, "Allergan" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical Associates Research Group" #1 collaborator was "Novo Nordisk A/S" with 2 trials as a collaborator, "PRA Health Sciences" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator, "Premier Research Group plc" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Medical Associates Research Group" are "Hepatitis C" (10 trials), "Hepatitis C, Chronic" (7 trials), "Nonalcoholic Steatohepatitis" (7 trials), "Crohn Disease" (6 trials) and "Irritable Bowel Syndrome" (6 trials). Many other conditions were trialed in "Medical Associates Research Group" in a lesser frequency.

Most popular intervention types in "Medical Associates Research Group" are "Drug" (79 trials), "Other" (9 trials), "Biological" (6 trials), "Diagnostic Test" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "RBV" (8 trials), "Ribavirin" (7 trials), "Daclatasvir" (5 trials) and "Sofosbuvir" (5 trials). Other intervention names were less common.

The vast majority of trials in "Medical Associates Research Group" are 82 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Medical Associates Research Group". undefined are not yet recruiting, 10 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Medical Associates Research Group, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Associates Research Group, 1 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 42 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".